Literature DB >> 27824815

Reply to "PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation".

Ronald M Evans1, Yihong Wan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27824815     DOI： 10.1038/nm.4207

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

Authors:  U Kornak; D Kasper; M R Bösl; E Kaiser; M Schweizer; A Schulz; W Friedrich; G Delling; T J Jentsch
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

2.  Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization.

Authors:  M Gowen; F Lazner; R Dodds; R Kapadia; J Feild; M Tavaria; I Bertoncello; F Drake; S Zavarselk; I Tellis; P Hertzog; C Debouck; I Kola
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

3.  TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.

Authors:  Betty Lamothe; YunJu Lai; Min Xie; Michael D Schneider; Bryant G Darnay
Journal:  Mol Cell Biol       Date:  2012-11-19       Impact factor: 4.272

4.  ASXL2 Regulates Glucose, Lipid, and Skeletal Homeostasis.

Authors:  Takashi Izawa; Nidhi Rohatgi; Tomohiro Fukunaga; Qun-Tian Wang; Matthew J Silva; Michael J Gardner; Michael L McDaniel; Nada A Abumrad; Clay F Semenkovich; Steven L Teitelbaum; Wei Zou
Journal:  Cell Rep       Date:  2015-06-04       Impact factor: 9.423

5.  Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

Authors:  V Iotsova; J Caamaño; J Loy; Y Yang; A Lewin; R Bravo
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

6.  Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course.

Authors:  E J Gerritsen; J M Vossen; I H van Loo; J Hermans; M H Helfrich; C Griscelli; A Fischer
Journal:  Pediatrics       Date:  1994-02       Impact factor: 7.124

7.  PPAR-gamma regulates osteoclastogenesis in mice.

Authors:  Yihong Wan; Ling-Wa Chong; Ronald M Evans
Journal:  Nat Med       Date:  2007-12-02       Impact factor: 53.440

8.  Mouse genome-wide association and systems genetics identify Asxl2 as a regulator of bone mineral density and osteoclastogenesis.

Authors:  Charles R Farber; Brian J Bennett; Luz Orozco; Wei Zou; Ana Lira; Emrah Kostem; Hyun Min Kang; Nicholas Furlotte; Ani Berberyan; Anatole Ghazalpour; Jaijam Suwanwela; Thomas A Drake; Eleazar Eskin; Q Tian Wang; Steven L Teitelbaum; Aldons J Lusis
Journal:  PLoS Genet       Date:  2011-04-07       Impact factor: 5.917

9.  A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis.

Authors:  Johan W Jonker; Jae Myoung Suh; Annette R Atkins; Maryam Ahmadian; Pingping Li; Jamie Whyte; Mingxiao He; Henry Juguilon; Yun-Qiang Yin; Colin T Phillips; Ruth T Yu; Jerrold M Olefsky; Robert R Henry; Michael Downes; Ronald M Evans
Journal:  Nature       Date:  2012-05-17       Impact factor: 49.962

10.  PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation.

Authors:  Wei Zou; Nidhi Rohatgi; Timothy Hung-Po Chen; Joel Schilling; Yousef Abu-Amer; Steven L Teitelbaum
Journal:  Nat Med       Date:  2016-11-08       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.